Lifetime and 12-month prevalence estimates for mental disorders in northeastern Germany: findings from the Study of Health in Pomerania.
Community
Comorbidity
Epidemiology
Frequency
Psychopathology
Journal
European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
16
02
2018
accepted:
31
05
2018
pubmed:
28
6
2018
medline:
27
8
2019
entrez:
28
6
2018
Statut:
ppublish
Résumé
Few epidemiological studies presented 12-month and lifetime prevalence estimates for DSM-IV mental disorders in the adult general population by sex and age up to very old age. From 2007 to 2010, DSM-IV mental disorders were assessed with the DIA-X/M-CIDI among N = 2400 participants (aged 29-89 years) from the Study of Health in Pomerania, an epidemiological study based on a two-stage stratified cluster sample randomly drawn from the adult general population in northeastern Germany. 36.3% of the sample was affected by any 12-month and 54.8% by any lifetime mental disorder. The most frequent diagnostic groups were anxiety (12-month: 14.8%, lifetime: 23.4%), substance use (12-month: 14.5%, lifetime: 25.0%), somatoform (12-month: 12.9%, lifetime: 20.4%) and depressive (12-month: 7.3%, lifetime: 18.6%) disorders. Except for substance use (higher prevalence in men) and bipolar disorders (comparable prevalence in men and women), higher 12-month and lifetime prevalence estimates were found in women vs. men. Moreover, lower 12-month and lifetime prevalence estimates were found in older (aged 60-74 or 75-89 years) vs. younger (aged 29-44 or 45-59 years) age groups. 22.6% (men: 21.1%, women: 23.9%) of those affected by any 12-month disorder met criteria for two and 13.6% (men: 9.6%, women: 16.9%) for three or more 12-month diagnoses. Similarly, 26.4% (men: 25.7%, women: 26.9%) of those affected by any lifetime disorder met criteria for two and 22.7% (men: 19.6%, women: 25.2%) for three or more lifetime diagnoses. Our findings demonstrate the frequency of mental disorders in northeastern Germany and emphasize the need for continued prevention and intervention efforts.
Identifiants
pubmed: 29948253
doi: 10.1007/s00406-018-0911-5
pii: 10.1007/s00406-018-0911-5
doi:
Types de publication
Journal Article
Langues
eng
Pagination
341-350Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01ZZ9603
Organisme : Bundesministerium für Bildung und Forschung
ID : 01ZZ0103
Organisme : Bundesministerium für Bildung und Forschung
ID : 01ZZ0403
Organisme : Deutsche Forschungsgemeinschaft
ID : GR1912/5-1
Références
Psychol Med. 1999 Jul;29(4):787-91
pubmed: 10473305
Psychol Med. 2000 Jan;30(1):11-22
pubmed: 10722172
Nervenarzt. 2000 Jul;71(7):535-42
pubmed: 10989807
Eur Arch Psychiatry Clin Neurosci. 2000;250(5):262-8
pubmed: 11097170
Psychol Med. 2004 May;34(4):597-611
pubmed: 15099415
Acta Psychiatr Scand Suppl. 2004;(420):21-7
pubmed: 15128384
Mol Psychiatry. 2005 Feb;10(2):220-4
pubmed: 15263905
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
World Psychiatry. 2007 Oct;6(3):168-76
pubmed: 18188442
Psychol Med. 2008 Nov;38(11):1659-69
pubmed: 18485262
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33
pubmed: 19378696
Aust N Z J Psychiatry. 2009 Jul;43(7):594-605
pubmed: 19530016
Psychol Med. 2010 Feb;40(2):225-37
pubmed: 19531277
Psychol Med. 2010 Jun;40(6):899-909
pubmed: 19719899
Depress Anxiety. 2010 Apr;27(4):351-64
pubmed: 20037917
Int J Epidemiol. 2011 Apr;40(2):294-307
pubmed: 20167617
Soc Psychiatry Psychiatr Epidemiol. 2012 Feb;47(2):203-13
pubmed: 21197531
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79
pubmed: 21924589
Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84
pubmed: 22865617
Psychiatr Prax. 2013 May;40(4):192-9
pubmed: 23564355
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Int J Methods Psychiatr Res. 2014 Sep;23(3):304-19
pubmed: 24729411
Int J Methods Psychiatr Res. 2015 Jun;24(2):116-29
pubmed: 25308743
Curr Psychiatry Rep. 2015 Feb;17(2):7
pubmed: 25617039
Soc Psychiatry Psychiatr Epidemiol. 2015 Jun;50(6):851-66
pubmed: 25982479
Eur Psychiatry. 2015 Sep;30(6):793-800
pubmed: 26169476
JAMA Psychiatry. 2015 Sep;72(9):892-9
pubmed: 26176785
Int J Methods Psychiatr Res. 2015 Dec;24(4):305-13
pubmed: 26184561
Br J Psychiatry. 2017 Feb;210(2):125-131
pubmed: 27609811
J Psychiatr Res. 1994 Mar-Apr;28(2):147-64
pubmed: 7932277
Eur Arch Psychiatry Clin Neurosci. 1995;245(6):272-87
pubmed: 8527464
Eur Arch Psychiatry Clin Neurosci. 1997;247(2):87-92
pubmed: 9177954
Soc Psychiatry Psychiatr Epidemiol. 1998 Nov;33(11):568-78
pubmed: 9803825